Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.61B | $2.62B | $2.78B | $3.03B | $3.11B | $4.22B | $4.54B | $5.14B | $5.46B | $5.94B |
| Revenue growth | — | 0.3% | 6.2% | 8.9% | 2.5% | 35.9% | 7.4% | 13.3% | 6.2% | 8.7% |
| Gross profit | $1.03B | $1.09B | $1.17B | $1.32B | $1.34B | $1.88B | $1.98B | $2.22B | $2.40B | $2.63B |
| Gross margin | 39.3% | 41.7% | 42.2% | 43.6% | 43.2% | 44.6% | 43.7% | 43.2% | 44.0% | 44.2% |
| Operating income | $226M | $400M | $411M | $537M | $548M | $478M | $791M | $836M | $867M | $1.10B |
| Operating margin | 8.7% | 15.3% | 14.8% | 17.7% | 17.6% | 11.3% | 17.4% | 16.3% | 15.9% | 18.6% |
| Net income | $110M | $291M | $304M | $408M | $397M | $244M | $107M | $378M | $615M | $782M |
| Net margin | 4.2% | 11.1% | 10.9% | 13.5% | 12.8% | 5.8% | 2.4% | 7.4% | 11.3% | 13.2% |
| EPS (diluted) | $1.28 | $3.39 | $3.55 | $4.76 | $4.63 | $2.48 | $1.07 | $3.81 | $6.20 | $7.93 |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $424M | $458M | $540M | $591M | $690M | $685M | $757M | $973M | $1.15B | $1.34B |
| Capital expenditures | $173M | $165M | $190M | $215M | $239M | $288M | $362M | $360M | $370M | $369M |
| Free cash flow | $251M | $292M | $350M | $376M | $450M | $397M | $395M | $613M | $778M | $972M |
| Share buybacks | $97.5M | $65.5M | $81.5M | $51.2M | $14.6M | $55.8M | $309M | $11.8M | $211M | $236M |
| Dividends paid | $93.2M | $103M | $113M | $123M | $134M | $163M | $183M | $201M | $220M | $242M |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $283M | $202M | $221M | $320M | $221M | $348M | $208M | $207M | $172M | $440M |
| Total assets | — | $5.20B | $5.07B | $5.44B | $6.57B | $11.4B | $10.8B | $11.1B | $10.1B | $10.7B |
| Total liabilities | — | $1.98B | $1.89B | $2.02B | $2.68B | $4.88B | $4.73B | $4.75B | $3.53B | $3.54B |
| Long-term debt | — | $1.32B | $1.18B | $1.15B | $1.65B | $2.95B | $3.02B | $3.12B | $1.92B | $1.81B |
| Shareholders' equity | $2.81B | $3.21B | $3.18B | $3.41B | $3.88B | $6.53B | $6.08B | $6.30B | $6.60B | $7.18B |
| Retained earnings | — | $1.15B | $1.34B | $1.66B | $1.94B | $2.00B | $1.91B | $2.09B | $2.48B | $3.02B |
| Shares (wtd avg diluted) | 86.1M | 85.7M | 85.5M | 85.6M | 85.9M | 98.3M | 100M | 99.4M | 99.1M | 98.7M |
Every figure is extracted from STERIS plc’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.